Bruderman Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bruderman Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-125	Closed	-$11K	–	581
2019 Q1	$11K	Hold	125	–	–	﹤0.01%	436
2018 Q4	$9K	Sell	125 -56,648	-100%	-$4.56M	﹤0.01%	447
2018 Q3	$5.44M	Buy	56,773 +7,509	+15%	+$728K	1.25%	30
2018 Q2	$4.69M	Buy	49,264 +5,218	+12%	+$480K	1.14%	30
2018 Q1	$3.86M	Buy	44,046 +4,044	+10%	+$369K	0.93%	36
2017 Q4	$3.4M	Buy	40,002 +4,167	+12%	+$349K	0.86%	38
2017 Q3	$3.1M	Buy	35,835 +5,177	+17%	+$415K	0.8%	36
2017 Q2	$2.37M	Buy	30,658 +3,980	+15%	+$282K	0.63%	42
2017 Q1	$1.85M	Buy	26,678 +1,793	+7%	+$120K	0.53%	47
2016 Q4	$1.47M	Buy	+24,885	New	+$1.54M	0.44%	53
2015 Q4	–	Sell	-205	Closed	-$13K	–	435
2015 Q3	$13K	Buy	+205	New	+$16.2K	0.01%	322

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bruderman Asset Management's XBI Position: Q2 2019 in Review

Bruderman Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 125 shares — an estimated $11K sold.

Bruderman Asset Management first reported a position in XBI in Q3 2015 and held it in 11 quarters. The position peaked at $5.44M in Q3 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Bruderman Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 125 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $11K.
Bruderman Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 11 quarters.
Bruderman Asset Management's State Street SPDR S&P Biotech ETF position peaked at $5.44M in Q3 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.